Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb;36(2):219-222.
doi: 10.1007/s10654-020-00716-2. Epub 2021 Feb 6.

Evidence of early circulation of SARS-CoV-2 in France: findings from the population-based "CONSTANCES" cohort

Affiliations

Evidence of early circulation of SARS-CoV-2 in France: findings from the population-based "CONSTANCES" cohort

Fabrice Carrat et al. Eur J Epidemiol. 2021 Feb.

Abstract

Using serum samples routinely collected in 9144 adults from a French general population-based cohort, we identified 353 participants with a positive anti-SARS-CoV-2 IgG test, among whom 13 were sampled between November 2019 and January 2020 and were confirmed by neutralizing antibodies testing. Investigations in 11 of these participants revealed experience of symptoms possibly related to a SARS-CoV-2 infection or situations at risk of potential SARS-CoV-2 exposure. This suggests early circulation of SARS-CoV-2 in Europe.

Keywords: COVID-19; Cohort; General population; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no conflict of interests.

Figures

Fig. 1
Fig. 1
Number of blood samples tested each week for anti-SARS-CoV-2 antibodies by ELISA-S IgG test (horizontal bars) and percentages of ELISA-S positive test (red dots, with exact 95% Confidence Interval) in adult participants from the CONSTANCES cohort, France
Fig. 2
Fig. 2
Participants with a positive ELISA-S or a positive SN anti-SARS-CoV-2 test in the CONSTANCES cohort

Comment in

References

    1. Deslandes A, Berti V, Tandjaoui-Lambotte Y, Alloui C, Carbonnelle E, Zahar JR, et al. SARS-CoV-2 was already spreading in France in late December 2019. Int J Antimicrob Agents. 2020;55(6):106006. doi: 10.1016/j.ijantimicag.2020.106006. - DOI - PMC - PubMed
    1. Gerbaud L, Guiguet-Auclair C, Breysse F, Odoul J, Ouchchane L, Peterschmitt J, et al. Hospital and population-based evidence for COVID-19 early circulation in the East of France. Int J Environ Res Public Health. 2020;17(19):7175. doi: 10.3390/ijerph17197175. - DOI - PMC - PubMed
    1. La Rosa G, Mancini P, Bonanno Ferraro G, Veneri C, Iaconelli M, Bonadonna L, et al. SARS-CoV-2 has been circulating in northern Italy since December 2019: evidence from environmental monitoring. Sci Total Environ. 2021;750:141711. doi: 10.1016/j.scitotenv.2020.141711. - DOI - PMC - PubMed
    1. Apolone G, Montomoli E, Manenti A, Boeri M, Sabia F, Hyseni I, et al. Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy. Tumori. 2020. 10.1177/0300891620974755. - PMC - PubMed
    1. Zins M, Goldberg M, Team C The French CONSTANCES population-based cohort: design, inclusion and follow-up. Eur J Epidemiol. 2015;30(12):1317–1328. doi: 10.1007/s10654-015-0096-4. - DOI - PMC - PubMed